A modified direct procedure is described for measuring serum iron (SI) levels and serum unsaturated iron-binding capacities (UIBC). Protein digestion or precipitation, as well as extraction of the color of the iron complex are eliminated.
SCHADE AND CO-WORKERS (1) iron and iron-binding capacity carried out in our laboratory during a period of 2 years.
Schade 's method makes use of the fact that at acid pH iron can be dissociated from human beta globulin (transferrin) and that at alkaline pH it can be bound to the beta globulin.
In normal individuals about one-third of the serum transferrin has bound iron; this is the serum iron. The remaining two-thirds is able to bind more iron and represents the unsaturated iron-binding capacity (UIBC).
For measuring the iron level the serum is incubated with a buffer at acid pH. The iron in the ferrous state then forms a colored complex with the terpyridine, and its concentration is determined from a standard curve.
For determining the UIBC the serum is incubated at an alkaline pH with a known amount of iron-enough to bind the free transferrin and to leave an excess of unbound iron. At this alkaline pH th#{128} bound iron is not available to react with terpyridine.
The amount of excess iron is thus measured quantitatively and subtracted from the known amount of iron originally added. This difference represents the TJIBC of the serum.
Materials

Phosphate
Buffer-Ascorbic Acid Reagent. Mix equal volumes of 1 M H3P04 (6.7 ml. of 85% phosphoric acid diluted to 100 ml.) and 1 M Na2HPO4 (14.2 gm. of analytical grade Na2HPO4 diluted to 100 ml.). Add 1 gm. of ascorbic acid to 100 ml. of this mixture and adjust the pH to 5.0 with 2N NaOH. Usually about 6 ml. are required. This solution is stable for 1 week. Dissolve 100 mg. 2,2',2"-terpyridine in 4 ml. of absolute ethanol and dilute approximately to 40 ml. with water. Clear the resulting milky suspension by the dropwise addition of 0.2N HC1 and then make up to 100 ml. volume. The final pH is 4.3.
Iron Standards.
Prepare from ferric ammoniuzn sulfate dissolved in dilute (approximately 0.005N) hydrochloric acid. One standard contains 3 g./ml. and is used to obtain the standard iron curve. A second standard containing 20 g./m1. is used in the IJIBC determination.
Blood. Specimens are collected with a Vacutainer needle into a tube that has been soaked in nitric acid diluted with an equal volume of water; rinsed thoroughly with deionized, distilled water; dried; and then partially evacuated with a vacuum pump. Water. All the water used in the analyses and also in the preparation of reagents is distilled water which has been passed through a mixed-bed ion-exchange resin.
Method Serum Iron
Pipet 0.6 ml. of the serum sample into each of two test tubes (13 X 100 mm.). To the first tube add 0.24 ml. of water, 0.24 ml. of phosphate buffer-ascorbic acid reagent, and 0.12 ml. of terpyridine, to make a total volume of 1.2 ml. To the second tube add 0.36 ml. of water, and 0.24 ml. of the buffered ascorbic acid reagent.
This second tube is a serum blank and compensates for the color of the serum sample.
Set up a terpyridine blank as in the first tube above with 0.6 ml. of water replacing the serum. Also set up a water blank as in the second tube above with water replacing the serum.
Run three iron standards containing 0.3, 0.6, and 0.9 pg., respectively; Table 1 
Results
Twenty-six sera from laboratory personnel and blood bank donors were analyzed to determine the "normal" range for iron levels. Fourteen of these were also analyzed for iron-binding capacities. A mean serum iron content of 98.0 pg./lOO ml. was found; mean iron binding capacity was 243 g./100 ml. Table 2 gives the pertinent information. Table 3 summarizes results obtained in various pathologic conditions. (4, 13) feel that the combined measurement of binding capacity and serum iron is superior in utility to that of iron alone, especially in connection with anemia and with liver diseases. In our group of 17 patients with these conditions, 2 had a normal iron level with an abnormal binding capacity, whereas out of the entire group of 42 patients 4 such were found. (Table 5, 6 ). If, however, we disregard those patients who showed both SI and TJIBC to be normal, then a measurement of SI alone would have failed in 18 per cent of the cases (4 of 22) to detect abnormalities in serum transferrin. 
